Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Gains from Investment Securities (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Gains from Investment Securities for 9 consecutive years, with -$4.5 million as the latest value for Q2 2025.

  • On a quarterly basis, Gains from Investment Securities fell 89.37% to -$4.5 million in Q2 2025 year-over-year; TTM through Sep 2025 was $14.2 million, a 19.59% decrease, with the full-year FY2024 number at $31.4 million, up 18378.24% from a year prior.
  • Gains from Investment Securities was -$4.5 million for Q2 2025 at SANUWAVE Health, down from $4.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $17.5 million in Q3 2024 to a low of -$6.7 million in Q2 2023.
  • A 3-year average of $3.2 million and a median of $1.3 million in 2023 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: soared 38773.33% in 2024, then plummeted 89.37% in 2025.
  • SANUWAVE Health's Gains from Investment Securities stood at $40000.0 in 2023, then soared by 34350.0% to $13.8 million in 2024, then plummeted by 132.45% to -$4.5 million in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Gains from Investment Securities are -$4.5 million (Q2 2025), $4.9 million (Q1 2025), and $13.8 million (Q4 2024).